A detailed history of Headlands Technologies LLC transactions in Novavax Inc stock. As of the latest transaction made, Headlands Technologies LLC holds 143,366 shares of NVAX stock, worth $1.37 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
143,366
Holding current value
$1.37 Million
% of portfolio
0.12%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

BUY
$5.43 - $7.74 $778,477 - $1.11 Million
143,366 New
143,366 $903,000
Q1 2024

May 07, 2024

BUY
$3.76 - $6.02 $189,804 - $303,889
50,480 Added 1083.96%
55,137 $263,000
Q4 2023

Feb 02, 2024

BUY
$4.8 - $7.67 $22,353 - $35,719
4,657 New
4,657 $22,000

Others Institutions Holding NVAX

About NOVAVAX INC


  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $747M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Headlands Technologies LLC Portfolio

Follow Headlands Technologies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Headlands Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Headlands Technologies LLC with notifications on news.